These potential targets include LPL and LPL-related proteins, such as apoCIII, apoCII, apoAV, ANGPTL4, and GPIHBP1, which cause alterations in TG levels and are related to the development of ASCVD. The gene discussed is APOA5; the disease is atherosclerosis.